Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin

Free Radical Research

Volumn 43, Issue 9, 2009, Pages 817-827

  Gandhi, Chintan ^a   Upaganalawar, Aman ^a   Balaraman, R ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Antioxidant; Hesperidin; Ischemia reperfusion injury; Reperfusion arrhythmias

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; HESPERIDIN; NITRITE; ANTIARRHYTHMIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CATALASE; CREATINE KINASE MB; GLUTATHIONE; MALONALDEHYDE; PEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMIC PARAMETERS; IN VIVO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; THERAPY EFFECT; TISSUE LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; BLOOD; BLOOD PRESSURE; DISEASE MODEL; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE; HEART RATE; HEART VENTRICLE PRESSURE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; BLOOD PRESSURE; CATALASE; CREATINE KINASE, MB FORM; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FEMALE; GLUTATHIONE; HEART RATE; HESPERIDIN; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRITES; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR PRESSURE;

EID: 70349329561     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760903071656     Document Type: Article

References (41)

1. Engin S, Ercument O, Ahmet A. Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats:can the incidence of sudden cardiac death be reduced? J Pineal Res 2002;32:194-198.
2. Wei AN, Jing Y. Protective effects of Ping-Lv-Mixture (PLM), a medicinal formula on arrhythmias induced by myocardial ischemia-reperfusion. J Ethnopharm 2006;108:90-95.
3. Andreas S, Rainer S, Gerd H. Pathophysiology of myocardial infarction protection by ischemic pre-and postconditioning. Herz 2008;33:88-100.
4. Silvia B, Russel JR. Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters. J Pineal Res 2007;42:55-63.
5. Devinder S, Kanwaljit C. Effect of trimetazidine on renal ischemia/reperfusion injury in rats. Pharm Res 2004;50: 623-629.
6. Mark SP, Thomas VN, Emily K, Marsha P. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation. Kidney Int 1991;40:1041-1049.
7. Cho J. Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin. Arch Pharm Res 2006;29: 699-706.
8. Naveen T, Sangeeta P, Anurag K, Kanwaljit C. Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol 2005;5:1-8.
9. Hosseinimehr SJ, Nemati A. Radioprotective effects of hesperidin against gamma irradiation in mouse bone marrow cells. Brit J Radiat 2006;79:415-418
10. Garg A, Garg S, Zaneveld LJ, Singla AK. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 2007;15:655-669.
11. Uma M, Rao P. Antihepatotoxic effect of grape seed oil in rat. Ind J Pharm 2005;37:179-182.
12. Walker MJA, Curtis MJ, Hearse DJ. The Lambeth conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 1988;22: 447-455.
13. Demiryurek AT, Yildiz G, Esiyok S, Altug S. Protective effects of poly (ADP-ribose) synthase inhibitors on digoxin-induced cardiotoxicity in guinea-pig isolated hearts. Pharmacol Res 2002;45:189-194.
14. Dias VJ, Ferreira NE, Salgado HC, Fazan R Jr. Chronic converting enzyme inhibition normalizes QT interval in aging rats. Braz J Med Biol Res 2002;35:1025-1031.
15. Hillegas LM, Griswold DE, Brickson B. Assessment of myeloperoxidase activity in whole rat kidney. J Pharm Methods 1990;24:285-295.
16. Lepoivre M, Chenais B, Yapo A. Alterations of ribonucleotide reductase activity following induction of nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 1990;6: 141-149.
17. Egan JR, Butler TL, Cole AD. Myocardial ischemia is more important than the effects of cardiopulmonary bypass on myocardial water handling and postoperative dysfunction: a pediatric animal model. J Thorac Cardiovasc Surg 2008;136:1-9.
18. Imaizumi S, Miura SI, Nakamura K. Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J Am Coll Cardiol 2008;51: 1604-1612.
19. Rui G, Han JW, Feng Z. Tempol reduces reperfusion-induced arrhythmias in anaesthetized rats. Pharm Res 2005;52: 192-198.
20. Rodrigo RN, Cereceda M, Castillo R. Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharm Ther 2008;118:104-127.
21. Balakrishnan A, Menon VP. Antioxidant properties of hesperidin in nicotine-induced lung toxicity. Fundam Clin Pharm 2007;21:535-546.
22. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005;100:179-190.
23. Schulz R, Dodge KL, Lopaschuk GD, Clanachan AS. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol 1997;41:212-219.
24. Das B, Sarkar C. Is the sarcolemmal or mitochondrial KATP channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Life Sci 2005;77: 1226-1248.
25. Woodcock EA, Arthur JF, Matkovich SJ. Inositol 1,4,5-trisphosphate and reperfusion arrhythmias. Clin Exp Pharm Phys 2000;27:734-737.
26. Gautier M, Zhang H, Fearon IM. Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents. J Mol Cell Cardiol 2008;44:241-251.
27. Yin H, Chao L, Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sci 2008;82:156-165.
28. Cheng CY, Su SY, Tang NY, Ho TY, Chiang SY, Hsieh CL. Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Res 2008;1209:136-150.
29. Hennebert O, Pelissier MA, Le MS, Wnlfert E, Morfin R. Anti-inflammatory effects and changes in prostaglandin patterns induced by 7[beta]-hydroxy- epiandrosterone in rats with colitis. J Steroid Biochem Mol Biol 2008;110:255-262.
30. Elahi MM, Yii M, Matata BM. Significance of oxidants and inflammatory mediators in blood of patients undergoing cardiac surgery. J Cardiothor Vasc Anesth 2008;22:455-467
31. Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol 2008;101: S58-S68.
32. Xiao H, Chen Z, Liao Y. Positive correlation of tumor necrosis factor-[alpha] early expression in myocardium and ventricular arrhythmias in rats with acute myocardial infarction. Arch Med Res 2008;39:285-291.
33. Okabe E, Takahashi SS, Norisue M. The effect of hypochlor-ous acid and hydrogen peroxide on coronary flow and arrhythmogenesis in myocardial ischemia and reperfusion. Eur J Pharm 1993;248:33-39.
34. Imani AL, Faghihi MA, Sadr SS, Keshav RZ, Niraki SS. Noradrenaline reduces ischemia-induced arrhythmia in anesthetized rats: involvement of alpha1-adrenoceptors and mitochondrial KATP channels. J Cardiovasc Electrophysiol 2008;19:309-315.
35. Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991;68:1713-1721.
36. Lou H, Kaur K, Sharma AK, Singal PK. Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes. Pathophysiology 2006;13:103-109.
37. Levrand S, Vannay BC, Pesse B. Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med 2006;41:886-895.
38. Sueur S, Pesant M, Rochette L, Connat JL. Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/ CRLR complex. J Mol Cell Cardiol 2005;39:955-963.
39. Jones EA, Shahed A, Shoskes DA. Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 2000;56:346-351.
40. Rodrigo RN, Castillo R, Cereceda M, Asenjo R, Zamorano J, Araya J. Non-hypoxic preconditioning of myocardium against postoperative atrial fibrillation: mechanism based on enhancement of the antioxidant defense system. Med Hypoth 2007;69:1242-1248.
41. Guney M, Oral B, Karahan N, Mungan T. Protective effect of caffeic acid phenethyl ester (CAPE) on fluoride-induced oxidative stress and apoptosis in rat endometrium. Environ Toxicol Pharm 2007;24:86-91.